7-Spiroindanyloxymorphone

7-Spiroindanyloxymorphone
Identifiers
	IUPAC name (4aR-(4aα,7aα,8α,9cα))-1',3',7,7a,8,9-Hexahydro-3,7a-dihydroxy-12-methylspiro[6H-8,9c](iminoethano)phenanthro[4,5-bcd]furan-6,2'-(2H)inden)-5(4aH)-one;
CAS Number	150380-34-0 ;
PubChem CID	5487084;
ChemSpider	8176808 ;
CompTox Dashboard (EPA)	DTXSID60933926 ;
Chemical and physical data
Formula	C25H25NO4
Molar mass	403.478 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CN1CCC23[C@@H]4C(=O)C5(CC6=CC=CC=C6C5)C[C@]2([C@@H]1CC7=C3C(=C(C=C7)O)O4)O;
	InChI InChI=1S/C25H25NO4/c1-26-9-8-24-19-14-6-7-17(27)20(19)30-22(24)21(28)23(13-25(24,29)18(26)10-14)11-15-4-2-3-5-16(15)12-23/h2-7,18,22,27,29H,8-13H2,1H3/t18?,22-,24-,25+/m0/s1 ; Key:YJWDKWRVFJZBCJ-OVKCVFHGSA-N ;
	(what is this?) (verify)

7-Spiroindanyloxymorphone (SIOM) is a drug that is used in scientific research. It is a selective δ-opioid agonist. It is a derivative of oxymorphone.^[1]^[2]^[3]^[4]^[5]

References

^ Portoghese PS, Moe ST, Takemori AE (August 1993). "A selective delta 1 opioid receptor agonist derived from oxymorphone. Evidence for separate recognition sites for delta 1 opioid receptor agonists and antagonists". Journal of Medicinal Chemistry. 36 (17): 2572–4. doi:10.1021/jm00069a017. PMID 8394935.
^ Fang X, Larson DL, Portoghese PS (September 1997). "7-spirobenzocyclohexyl derivatives of naltrexone, oxymorphone, and hydromorphone as selective opioid receptor ligands". Journal of Medicinal Chemistry. 40 (19): 3064–70. doi:10.1021/jm970283e. PMID 9301669.
^ Ohkawa S, DiGiacomo B, Larson DL, Takemori AE, Portoghese PS (May 1997). "7-Spiroindanyl derivatives of naltrexone and oxymorphone as selective ligands for delta opioid receptors". Journal of Medicinal Chemistry. 40 (11): 1720–5. doi:10.1021/jm9700880. PMID 9171881.
^ Kshirsagar TA, Fang X, Portoghese PS (July 1998). "14-Desoxy analogues of naltrindole and 7-spiroindanyloxymorphone: the role of the 14-hydroxy group at delta opioid receptors". Journal of Medicinal Chemistry. 41 (14): 2657–60. doi:10.1021/jm980209b. PMID 9651172.
^ Shenderovich MD, Liao S, Qian X, Hruby VJ (June 2000). "A three-dimensional model of the delta-opioid pharmacophore: comparative molecular modeling of peptide and nonpeptide ligands". Biopolymers. 53 (7): 565–80. doi:10.1002/(SICI)1097-0282(200006)53:7<565::AID-BIP4>3.0.CO;2-5. PMID 10766952.

This analgesic-related article is a stub. You can help Wikipedia by expanding it.

[1] Portoghese PS, Moe ST, Takemori AE (August 1993). "A selective delta 1 opioid receptor agonist derived from oxymorphone. Evidence for separate recognition sites for delta 1 opioid receptor agonists and antagonists". Journal of Medicinal Chemistry. 36 (17): 2572–4. doi:10.1021/jm00069a017. PMID 8394935.

[2] Fang X, Larson DL, Portoghese PS (September 1997). "7-spirobenzocyclohexyl derivatives of naltrexone, oxymorphone, and hydromorphone as selective opioid receptor ligands". Journal of Medicinal Chemistry. 40 (19): 3064–70. doi:10.1021/jm970283e. PMID 9301669.

[3] Ohkawa S, DiGiacomo B, Larson DL, Takemori AE, Portoghese PS (May 1997). "7-Spiroindanyl derivatives of naltrexone and oxymorphone as selective ligands for delta opioid receptors". Journal of Medicinal Chemistry. 40 (11): 1720–5. doi:10.1021/jm9700880. PMID 9171881.

[4] Kshirsagar TA, Fang X, Portoghese PS (July 1998). "14-Desoxy analogues of naltrindole and 7-spiroindanyloxymorphone: the role of the 14-hydroxy group at delta opioid receptors". Journal of Medicinal Chemistry. 41 (14): 2657–60. doi:10.1021/jm980209b. PMID 9651172.

[5] Shenderovich MD, Liao S, Qian X, Hruby VJ (June 2000). "A three-dimensional model of the delta-opioid pharmacophore: comparative molecular modeling of peptide and nonpeptide ligands". Biopolymers. 53 (7): 565–80. doi:10.1002/(SICI)1097-0282(200006)53:7<565::AID-BIP4>3.0.CO;2-5. PMID 10766952.

[1]

[2]

[3]

[4]

[5]